Buy or sell Atomwise stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Atomwise Stock
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
About Atomwise Stock
The Atomwise Advantage Using computers to discover medicines is a great idea, but execution is everything. With lives and budgets on the line, accuracy matters. Previous attempts haven't always met expectations. The techniques of the day were limited by the knowledge and computers available. Today, things are different. They have invented cutting-edge machine learning algorithms that are built specifically for the world's most powerful computers. They use one of the world's top supercomputers to analyze databases 1000 times larger than those used in the past. This lets us deliver what many others can't: precise and reliable medicinal predictions.
Funding History
January 2013 | $225K |
---|---|
December 2014 | $120K |
March 2015 | $225K |
June 2015 | $6.0M |
Management
CEO
Abraham Heifets
CTO
Dr. Izhar Wallach
COO
Alexander Levy
Press
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase